Target
Interleukin-17A
Ligand
BDBM419139
Substrate
n/a
Meas. Tech.
I L-17A Secretion
IC50
<100±n/a nM
Citation
 Musicki, BBouix-Peter, COuvry, GThoreau, E Benzenesulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (RORγ(T)) US Patent  US10457637 Publication Date 10/29/2019
Target
Name:
Interleukin-17A
Synonyms:
CTLA8 | Cytotoxic T-lymphocyte-associated antigen 8 | IL-17 | il-17a
Type:
Enzyme Catalytic Domain
Mol. Mass.:
17511.44
Organism:
Homo sapiens (Human)
Description:
Q16552
Residue:
155
Sequence:
MTPGKTSLVSLLLLLSLEAIVKAGITIPRNPGCPNSEDKNFPRTVMVNLNIHNRNTNTNPKRSSDYYNRSTSPWNLHRNEDPERYPSVIWEAKCRHLGCINADGNVDYHMNSVPIQQEILVLRREPPHCPNSFRLEKILVSVGCTCVTPIVHHVA
  
Inhibitor
Name:
BDBM419139
Synonyms:
BDBM50461078 | N-(4-ethylphenyl)-N- isobutyl-3- methanesulfonoximino-4- (tetrahydropyran-4- ylmethoxy)benzene- sulfonamide | US10457637, Compound 26
Type:
Small organic molecule
Emp. Form.:
C25H36N2O5S2
Mol. Mass.:
508.694
SMILES:
CCc1ccc(cc1)N(CC(C)C)S(=O)(=O)c1ccc(OCC2CCOCC2)c(c1)[S@](C)(=N)=O |r|
Structure:
Search PDB for entries with ligand similarity: